🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT06038097
Starting soon Not applicable

Efficacy and Safety of Radiofrequency Pallidotomy in the Management of Dystonia

NCT06038097 · tracked via the Priya Life Science India tracker
Sponsor
All India Institute of Medical Sciences
Phase
Not applicable
Started
2023-10-01
Last updated
2023-09-14

Condition(s) studied

Dystonia

Investigational drug(s) / intervention(s)

Radiofrequency Pallidotomy

Radiofrequency Pallidotomy: Radiofrequency bilateral simultaneous pallidotomy

Study summary

Generalized dystonia is treated with pallidotomy. This is based on observational data which is significantly limited by publication bias and there are no RCTs. The case reports focus on successful outcomes and case series have an inherent selection bias. Bilateral pallidotomy has been used in our institute in a series of patients with generalized and segmental dystonia and have been seen to show good efficacy. However, the existing literature suggests that it is also associated with dysphagia and dysarthria in some cases and thus simultaneous bilateral pallidotomy is not preferred in several centres. However, our center routinely performs simultaneous bilateral pallidotomy.

The response rates and compliations of the procedure have not been systematically studied in RCT and we need to generate data on the efficacy and safety of Pallidotomy on generalized and segmental dystonia. This randomized controlled trial will fill the void in knowledge in this field.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Patients with generalized, segmental or focal dystonias who are being considered for simultaneous bilateral radiofrequency pallidotomy. 2. Of all ages and gender Exclusion Criteria: 1. Those who deny consent 2. Pregnant ladies and women of childbearing potential without adequate contraception 3. Those who have undergone botulinum toxin injection in the last 12 weeks or those who are being planned for the same in the upcoming 12 weeks.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
All India Institute of Medical Sciences, New Delhi New Delhi National Capital Territory of Delhi

More All India Institute of Medical Sciences trials in India

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06038097 on ClinicalTrials.gov ↗ ← All trials in India